Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

1 structures for Q2KIA6

Entry ID Method Resolution Chain Position Source
AF-Q2KIA6-F1 Predicted AlphaFoldDB

No variants for Q2KIA6

Variant ID(s) Position Change Description Diseaes Association Provenance
No variants for Q2KIA6

No associated diseases with Q2KIA6

3 regional properties for Q2KIA6

Type Name Position InterPro Accession
domain PWI domain 1 - 87 IPR002483
domain Small nuclear ribonucleoprotein Prp3, C-terminal domain 545 - 673 IPR010541
domain Pre-mRNA-splicing factor 3 domain 308 - 521 IPR013881

Functions

Description
EC Number
Subcellular Localization
  • Nucleus
  • Nucleus speckle
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

4 GO annotations of cellular component

Name Definition
nuclear speck A discrete extra-nucleolar subnuclear domain, 20-50 in number, in which splicing factors are seen to be localized by immunofluorescence microscopy.
nucleus A membrane-bounded organelle of eukaryotic cells in which chromosomes are housed and replicated. In most cells, the nucleus contains all of the cell's chromosomes except the organellar chromosomes, and is the site of RNA synthesis and processing. In some species, or in specialized cell types, RNA metabolism or DNA replication may be absent.
spliceosomal complex Any of a series of ribonucleoprotein complexes that contain snRNA(s) and small nuclear ribonucleoproteins (snRNPs), and are formed sequentially during the spliceosomal splicing of one or more substrate RNAs, and which also contain the RNA substrate(s) from the initial target RNAs of splicing, the splicing intermediate RNA(s), to the final RNA products. During cis-splicing, the initial target RNA is a single, contiguous RNA transcript, whether mRNA, snoRNA, etc., and the released products are a spliced RNA and an excised intron, generally as a lariat structure. During trans-splicing, there are two initial substrate RNAs, the spliced leader RNA and a pre-mRNA.
U4/U6 x U5 tri-snRNP complex A ribonucleoprotein complex that is formed by the association of the U4/U6 and U5 snRNPs.

No GO annotations of molecular function

Name Definition
No GO annotations for molecular function

2 GO annotations of biological process

Name Definition
mRNA splicing, via spliceosome The joining together of exons from one or more primary transcripts of messenger RNA (mRNA) and the excision of intron sequences, via a spliceosomal mechanism, so that mRNA consisting only of the joined exons is produced.
spliceosomal tri-snRNP complex assembly The formation of a tri-snRNP complex containing U4 and U6 (or U4atac and U6atac) snRNAs and U5 snRNAs and associated proteins. This includes reannealing of U4 and U6 (or U4atac and U6atac) snRNAs released from previous rounds of splicing to reform the U4/U6 snRNP (or U4atac/U6atac snRNP) as well as the subsequent association of the U5 snRNP with the U4/U6 snRNP (or U4atac/U6atac snRNP) to form a tri-snRNP that is ready to reassemble into another spliceosome complex.

3 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
Q5ZJ85 PRPF3 U4/U6 small nuclear ribonucleoprotein Prp3 Gallus gallus (Chicken) PR
O43395 PRPF3 U4/U6 small nuclear ribonucleoprotein Prp3 Homo sapiens (Human) PR
Q922U1 Prpf3 U4/U6 small nuclear ribonucleoprotein Prp3 Mus musculus (Mouse) PR
10 20 30 40 50 60
MALSKRELDE LKPWIEKTVE RVLGFSEPTV VTAALNCVGK GMDKKKAADH LKPFLDDSTL
70 80 90 100 110 120
RFVDKLFEAV EEGRSSRHSK SSSDRSRKRD LKEVFGDDSE ISKESSGVKK RRIPRFEEVE
130 140 150 160 170 180
EEPEVIPGPP SESPGMLTKL QIKQMMEAAT RQIEERKKQL SFISPPTPQP KTPSSSQPER
190 200 210 220 230 240
LPIGNTIQPS QAATFMNDAI EKARKAAELQ ASIQAQLALK PGLIGNANMV GLANLHAMGI
250 260 270 280 290 300
APPKVELKDQ TKPTPLILDE QGRTVDATGK EIELTHRMPT LKANIRAVKR EQFKQQLKEK
310 320 330 340 350 360
PSEDMESNTF FDPRVSIAPS QRQRRTFKFH DKGKFEKIAQ RLRTKAQLEK LQAEISQAAR
370 380 390 400 410 420
KTGIHTSTRL ALIAPKKELK EGDIPEIEWW DSYIIPNGFD LTEENPKRED YFGITNLVEH
430 440 450 460 470 480
PAQLNPPVDN DTPVTLGVYL TKKEQKKLRR QTRREAQKEL QEKVRLGLMP PPEPKVRISN
490 500 510 520 530 540
LMRVLGTEAV QDPTKVEAHV RAQMAKRQKA HEEANAARKL TAEQRKVKKI KKLKEDISQG
550 560 570 580 590 600
VHISVYRVRN LSNPAKKFKI EANAGQLYLT GVVVLHKDVN VVVVEGGPKA QKKFKRLMLH
610 620 630 640 650 660
RIKWDEQTSN TKGDDDEESD EEAVKKTNKC VLVWEGTAKD RSFGEMKFKQ CPTENMAREH
670 680
FKKHGAEHYW DLALSESVLE STD